Are you kidding me? Your hemo isn't aware of quinine/ITP? There most certainly is an antibody test and quinine induced ITP is widely known. Yes, I know about TTP and it is a very, very scary disorder that makes ITP look like a walk in the park.
www.psbc.org/lab_platelet/test03.htm
The Indium is done in the UK, not in the U.S. It can be a waste of time and the only thing it can do is save the spleen if it's determined that the liver is destroying platelets. One woman here had it and did not get a splenectomy for that reason. If the test does determine that platelets are destroyed in the spleen, that doesn't mean that the liver won't take over that destruction in the future and the splenectomy can fail.
KO - again, the cause doesn't matter. They can't fix it. As I said before, none of the 88 autoimmune disorders have known causes or cures. ITP is no different. All that is available are treatments. I don't like it either, but after researching for 13 years, it is what it is. What other illness are you seeing that have better treatments? Actually, ITP treatments have advanced tremendously in the past 10 years. For the longest time, the only things available were Prednisone, IVIG and splenectomy. ITP has come a long way. I have Lupus and my daughter has Graves and those treatments are just as nasty and barbaric.
I posted this on the old forum; it might be helpful:
When diagnosed with ITP, most of us keep asking why this happened. We blame ourselves, blame medications, blame foods, etc. We can't accept the fact that there is no real explanation or fix. The summary below partially answers the question why and shows why ITP, and most autoimmune disorders, are more complicated than we realize, and why you can't just cure it.
"Gene copy number variation (CNV) and single nucleotide polymorphisms (SNPs) count as important sources for inter-individual differences, including differential responsiveness to infection or predisposition to autoimmune disease as a result of unbalanced immunity. By developing a FCGR-specific multiplex ligation-dependent probe amplification assay we were able to study a notoriously complex and highly homologous region in the human genome and demonstrate extensive variation in the FCGR2 and FCGR3 gene clusters, including previously unrecognized CNV. As indicated by the prevalence of an open reading frame of FCGR2C, Fc receptor (FcR) type IIc is expressed in 18% of healthy individuals and is strongly associated with the hematological autoimmune disease idiopathic thrombocytopenic purpura (present in 34.4% of ITP patients; OR 2.4 (1.3-4.5), p<0.009). FcRIIc acts as an activating IgG receptor that exerts antibody-mediated cellular cytotoxicity by immune cells. Therefore, we propose that the activating FCGR2C-ORF genotype predisposes to ITP by altering the balance of activating and inhibitory FcR on immune cells."
bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-2007-03-079913v1?ct